Structural and functional analysis of intra-articular interzone tissue in axolotl salamanders.
OBJECTIVE
Knowledge of mechanisms directing diarthrodial joint development may be useful in understanding joint pathologies and identifying new therapies. We have previously established that axolotl salamanders can fully repair large articular cartilage lesions, which may be due to the presence of an interzone-like tissue in the intra-articular space. Study objectives were to further characterize axolotl diarthrodial joint structure and determine the differentiation potential of interzone-like tissue in a skeletal microenvironment.


METHODS
Diarthrodial joint morphology and expression of aggrecan, brother of CDO (BOC), type I collagen, type II collagen, and growth/differentiation factor 5 (GDF5) were examined in femorotibial joints of sexually mature (>12 months) axolotls. Joint tissue cellularity was evaluated in individuals from 2 to 24 months of age. Chondrogenic potential of the interzone was evaluated by placing interzone-like tissue into 4 mm tibial defects.


RESULTS
Cavitation reached completion in the femoroacetabular and humeroradial joints, but an interzone-like tissue was retained in the intra-articular space of distal limb joints. Joint tissue cellularity decreased to 7 months of age and then remained stable. Gene expression patterns of joint markers are broadly similar in developing mammals and mature axolotls. When interzone-like tissue was transplanted into critical size skeletal defects, an accessory joint developed within the defect site.


CONCLUSIONS
These experiments indicate that mature axolotl diarthrodial joints are phenotypically similar to developing synovial joints in mammals. Generation of an accessory joint by interzone-like tissue suggests multipotent cellular differentiation potential similar to that of interzone cells in the mammalian fetus. The data support the axolotl as a novel vertebrate model for joint development and repair.
Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
R S
RS
Cosden-Decker
M M
MM
Bickett
C
C
Lattermann
J N
JN
MacLeod
D053674:Aggrecans / Q000378:metabolism; D000558:Ambystoma mexicanum; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D002357:Cartilage Diseases / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D002358:Cartilage, Articular / Q000033:anatomy & histology* / Q000293:injuries / Q000378:metabolism; D060833:Cellular Microenvironment / Q000502:physiology; D020219:Chondrogenesis / Q000502:physiology*; D024042:Collagen Type I / Q000378:metabolism; D024043:Collagen Type II / Q000378:metabolism; D004195:Disease Models, Animal; D005109:Extracellular Matrix / Q000378:metabolism* / Q000637:transplantation; D055428:Growth Differentiation Factor 5 / Q000378:metabolism; D007596:Joints / Q000033:anatomy & histology* / Q000293:injuries / Q000378:metabolism; D030781:Organisms, Genetically Modified; D011956:Receptors, Cell Surface / Q000378:metabolism; D012038:Regeneration / Q000502:physiology
D053674:Aggrecans; D015415:Biomarkers; D024042:Collagen Type I; D024043:Collagen Type II; D055428:Growth Differentiation Factor 5; D011956:Receptors, Cell Surface